Coby Health tirzepatide review
Advertised at $179, billed at $239. Position 9 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
$239 a month month-to-month or about $179 multi-month, with injection supplies in the box and no membership.
Advertised at $299 and discounted to $239 monthly. Multi-month plans reach roughly $179. Monthly plans genuinely cancel at any time.
The numbers
| Coby Health · tirzepatide | |
|---|---|
| Advertised | $179/mo |
| Membership | None |
| Billed | $239/mo |
| Advertised-to-billed gap | +$60/mo |
| Per year | $2,868 |
| Board position | 9 of 18, cheapest first |
The $179 requires a multi-month commitment; month-to-month is $239 with no membership behind it.
Where the gap is
The $179 requires a multi-month commitment — a $60 gap against the month-to-month figure, disclosed clearly.
Against the board
About $2,148 to $2,868 a year. Cheaper half of the board, without needing a twelve-month commitment to get there.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Compounded GLP-1 provider selling monthly and multi-month plans with an at-home injection kit included in the price.
Verified facts
- Compounded tirzepatide listed at $239/month on the monthly plan, down from $299.
- Multi-month plans bring compounded tirzepatide to about $179/month.
- An at-home injection kit with alcohol pads and syringes is included.
- Monthly plans can be cancelled at any time.
- States plainly on its own product pages that compounded medication is not FDA-reviewed or approved.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Injection supplies are included rather than something you source yourself.
- Monthly plan is genuinely cancel-anytime.
- Unusually clear on its own pages that the product is not FDA-approved.
Against it
- The lowest advertised rate requires a multi-month commitment.
- Less published detail on clinical support than the larger platforms.
Read this bit. The $179 figure is a multi-month rate. Month-to-month is $239.
Score
3.6 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.7 / 5 |
| Price honesty | 20% | 3.6 / 5 |
| Clinical support | 20% | 3.3 / 5 |
| Pharmacy sourcing | 15% | 3.4 / 5 |
| Cancelling | 15% | 3.7 / 5 |
Verdict
Fair pricing, supplies included, and unusually blunt on its own pages about compounded medication not being FDA-approved.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.